Abscisic acid transport in human erythrocytes by Vigliarolo, Tiziana et al.
Abscisic Acid Transport in Human Erythrocytes*
Received for publication,December 1, 2014, and in revised form, March 3, 2015 Published, JBC Papers in Press, April 6, 2015, DOI 10.1074/jbc.M114.629501
Tiziana Vigliarolo‡1, Lucrezia Guida‡, Enrico Millo§, Chiara Fresia‡, Emilia Turco¶, Antonio De Flora‡,
and Elena Zocchi‡
From the ‡Department of Experimental Medicine, Section of Biochemistry, and the §Center of Excellence for Biomedical Research,
University of Genova, Genova 16132, Italy and the ¶Department of Molecular Biotechnology and Health Sciences, University of
Torino, Torino 10126, Italy
Background: The plant stress hormone abscisic acid (ABA) is present and active in mammalian cells.
Results: Band 3 protein is required for ABA influx into red blood cells (RBC); intracellular ABA activates adenylate cyclase
resulting in [cAMP]i increase and subsequent ATP release.
Conclusion: ABA influx through Band 3 activates ATP release from RBC.
Significance: Paracrine ABA may regulate the ATP-mediated vasodilator response to inflammation.
Abscisic acid (ABA) is a plant hormone involved in the
response to environmental stress. Recently, ABA has been
shown to be present and active also in mammals, where it stim-
ulates the functional activity of innate immune cells, of mesen-
chymal and hemopoietic stem cells, and insulin-releasing pan-
creatic-cells. LANCL2, the ABA receptor inmammalian cells,
is a peripheral membrane protein that localizes at the intracel-
lular side of the plasma membrane. Here we investigated the
mechanism enabling ABA transport across the plasmamem-
brane of human red blood cells (RBC). Both influx and efflux of
[3H]ABA occur across intact RBC, as detected by radiometric
and chromatographic methods. ABA binds specifically to Band
3 (the RBC anion transporter), as determined by labeling of RBC
membranes with biotinylated ABA. Proteoliposomes reconsti-
tuted with human purified Band 3 transport [3H]ABA and
[35S]sulfate, and ABA transport is sensitive to the specific Band
3 inhibitor 4,4-diisothiocyanostilbene-2,2-disulfonic acid.
Once inside RBC, ABA stimulates ATP release through the
LANCL2-mediated activation of adenylate cyclase. As ATP
released from RBC is known to exert a vasodilator response,
these results suggest a role for plasma ABA in the regulation of
vascular tone.
Abscisic acid (ABA)2 is a plant hormone regulating several
important functions in higher plants, including response to abi-
otic stress, control of stomatal closure, and regulation of seed
germination (1, 2). In plants, several ABA receptors with differ-
ent cellular localizations have been identified (3). Recent stud-
ies identified PYR/PYL/RCAR proteins as ABA receptors that
are localized in the cytosol and nucleus (4, 5). Because PYR/
PYL/RCAR are intracellular soluble receptors and ABAmay be
produced by cell types different from those that are functionally
responsive to the hormone,ABA transport across the cellmem-
branes is necessary to the action of the hormone. Indeed, sev-
eral ABA transporters have been recently identified in plants.
Two members of the ATP-binding cassette (ABC) transporter
family, AtABCC25 and AtABCG40, were found to function as
ABA transporters (6, 7) and another type of ABA transporter,
AIT1/NRT1.2 (nitrate transporter family), was identified
as an ABA influx facilitator (8). These transporters are involved
in ABA efflux and influx with tissue-specific expression. Very
recently, an Arabidopsis DTX/MATE family member, DTX50,
has been shown to function as a mediator of ABA efflux (9).
Several reports have demonstrated that ABA is present and
functionally active in awide range of animals, from lowerMeta-
zoa to a variety of mammalian tissues and cells (10, 11). In
human granulocytes and other cells of the innate immune
response, ABA stimulates cell-specific functions, such as phag-
ocytosis, chemotaxis, reactive oxygen species, and nitric oxide
production (12–14). ABA also expands human mesenchymal
stem cells (15) and human hemopoietic progenitors (16). In
cells involved in the control of systemic glucose homeostasis,
ABA is an endogenous stimulator of insulin release from pan-
creatic  cells and an enhancer of glucose uptake by adipocytes
and myoblasts (17). It was previously suggested that the lanthi-
onine synthetase C-like protein 2 (LANCL2) is required for
ABA binding to the plasma membrane of granulocytes and is
necessary for the transduction of the ABA signal in granulo-
cytes and in rat insulinoma cells (18). More recently, docking
studies predicted (19), and experiments with the recombinant
protein demonstrated (20), ABA binding to LANCL2. The
LANCL2 protein is associated with the plasma membrane
through N-terminal myristoylation and a basic phosphatidyli-
nositol phosphate-binding site (21). However, protein lipida-
tion, a typical feature of peripheral membrane proteins, has
been recently observed in integral membrane proteins as well
(22), and previous immunofluorescence studies performed on
LANCL2-overexpressing cells were inconclusive regarding the
transmembrane or peripheral position of LANCL2 (18). Here,
we investigated LANCL2 localization in human erythrocytes,
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and found that LANCL2 is a peripheral protein attached to the
intracellular side of the RBCmembrane; thus, for ABA to enter
into RBC and bind to its receptor, ABA transport across the
plasma membrane is necessary. We further provide direct evi-
dence, by different methodological approaches, that the trans-
membrane anion exchange protein Band 3 mediates ABA
influx into erythrocytes and that extracellular ABA stimulates
ATP release from intact RBC via LANCL2-mediated adenylate
cyclase activation.
Experimental Procedures
Materials—(R,S)-[3H]Abscisic acid ([3H]ABA) was pur-
chased from Biotrend Radiochemicals, Köln, Germany (20
Ci/mmol), [3H]NAD (25Ci/mmol) and [35S]sulfate (755mCi/
mmol) were obtained from PerkinElmer Life Sciences (Milan,
Italy).
Biotinylated abscisic acid (bio-ABA) was synthesized from
()2-cis, 4-trans abscisic acid by coupling ()-biotin--amino-
caproyl hydrazide to the carbonylic group on the ABA carbon
ring via an -aminocaproyl hydrazide linker, as described inRef.
23. All chemicals were obtained from Sigma (Italy). ABA was
dissolved in H2O at a concentration of 50 mM, the pH was
adjusted to 7.4 with NaOH or dissolved in Tris-HCl, 0.1 M, pH
7.4, at a concentration of 50 mM and the stock solutions were
kept at20 °C.
Preparation of a Monoclonal Antibody against Human
LANCL2—The monoclonal antibody (mAb) against LANCL2
was obtained at the Molecular Biotechnology Center (MBC) in
Torino (Italy), by fusing myeloma cells (NS1) with the spleen
cells from a mouse immunized with the recombinant fusion
protein LANCL2-GST obtained in Escherichia coli (20). One
subclone was selected for its high specificity (i.e. no cross-reac-
tivity toward the homolog LANCL1 protein), and best sensitiv-
ity for Western blotting, immunoprecipitation, and ELISA
applications on various cell lysates.
The anti-LANCL2 mAb was affinity purified from ascites
fluid or from the medium of cultured hybridoma cells on pro-
tein A-Sepharose, as described previously (24). Bound antibod-
ies were eluted with 0.1 M glycine, pH 3, and dialyzed against
PBS. Stock solutions of mAb at 2 and 0.2 mg/ml in PBS were
kept at 4 °C.
Preparation of Erythrocyte Membranes (White Ghosts)—
Freshly drawn blood samples were obtained from healthy
human volunteers. Washed, packed erythrocytes were hemo-
lyzed in 10 volumes of ice-cold 5 mM sodium phosphate
(Na2HPO4, hypotonic buffer), pH 8.0, containing 80 g/ml of
PMSF and 2 mM EDTA, and centrifuged at 15,000  g for 20
min at 4 °C. Erythrocyte ghosts were further washed several
times in 10 volumes of the same buffer, to obtain complete
removal of hemoglobin, and once in deionized H2O. The final
pellet was resuspended at 1 mg/ml in H2O and used directly or
kept frozen at 20 °C. Protein assays were performed accord-
ing to Bradford (25).White ghosts were resealed as described in
Ref. 26.
Stripping of Peripheral Proteins from Ghosts and Western
Blot—Extrinsic proteins were removed from 1 ml of white
ghosts at 1 mg/ml by sequential washing with the following
ice-cold buffers: (i) oncewith 10 volumes of 2mMEDTA, pH12;
(ii) three times with 10 volumes of 1 M KI, and (iii) once with
water. After each washing, the membranes were centrifuged at
4 °C, 100,000 g for 10min; finally, pellets were resuspended at
1mg/ml inH2O. In the experiments for LANCL2 localization in
ghosts, supernatants were collected and concentrated with an
Amicon Ultra, Ultracel 30k (Millipore, Milan, Italy). LANCL2
protein expression was determined by Western blot using the
monoclonal antibody against LANCL2 (see above): after SDS-
PAGE, performed according to the standard method on 10%
gels, proteins were transferred to a 0.2-mnitrocellulosemem-
brane (Bio-Rad). Blots were probed with a primary LANCL2
mouse monoclonal antibody and a secondary anti-mouse IgG
antibody conjugated with horseradish peroxidase (HRP) (Santa
Cruz Biotechnology) and developed with ImmobilonTM West-
ern Chemiluminescent HRP Substrate (Millipore). Detection
and densitometry were performed using a Chemi-Doc System
(Bio-Rad).
Transport Assay in Erythrocytes—Fifty-l aliquots of RBC at
a 5% hematocrit in Hanks’ balanced salt solution (HBSS) were
incubated at 22 °C in triplicate with 3.5, 7, 14, 28, 56, 114, 200,
and 300 nM [3H]ABA for 30 s with 100 nM [3H]ABA or, for the
time course experiments, with 200 nM [3H]ABA for 0.5, 3, 5, 15,
30, and 60 min. After incubation, RBC were washed 3 times in
ice-cold HBSS. In the experiments with chloride-free buffer,
RBC were washed 4 times with sodium citrate buffer (80 mM
Na-citrate, pH 7.4). The cells were resuspended at a 5% hema-
tocrit in HBSS or in citrate buffer and were incubated with 200
nM [3H]ABA or 3.5 M [35S]sulfate for 5 min in the presence or
absence of 100 mM NaCl.
RBC were then centrifuged for 15 s at 16,000 g, the super-
natants were discarded and the cell pellets were washed once
with 1.5 ml of ice-cold HBSS or citrate buffer. Cells were resus-
pended in 200 l of 5.5 M H2O2 and after 18 h the radioactivity
of the samples was determined after addition of 5.0 ml of
Ultima-Gold (PerkinElmer Life Sciences, Milan, Italy) using a
Packard -counter (Beckman-Coulter, Krefeld, Germany).
To evaluate ABA efflux from RBC, cells were incubated at
22 °C at a 5% hematocrit in HBSS buffer in 50l final volume at
22 °C in triplicate for 30 min with 200 nM [3H]ABA. The pellets
were then washed with 1.5 ml of HBSS for 4 times at 37 °C.
Intracellular radioactivity was estimated as described above.
HPLC—Fifty-l aliquots of RBC at a 50% hematocrit were
incubated in duplicate for 30 s in 50l of HBSSwith 0.025, 0.25,
2.5, 10, and 25mMABA. Cells were washed twice with 1.6ml of
ice-cold HBSS, resuspended in 100 l of H2O, extracted with 4
volumes of ice-cold acetone and stored at20 °C. The extracts
were centrifuged for 5 min at 16,000  g, and after removal of
acetone from the supernatants, the aqueous extract was acidi-
fied at pH 2.6 with trifluoroacetic acid and extracted with
diethyl ether (27). After removal of diethyl ether under a nitro-
gen flux the extract was re-dissolved in H2O and subjected to
HPLC analysis with a Hewlett-Packard HP1200 instrument.
The columnwas anAtlantis C18 (3.9 150mm, 5m,Waters,
Milan, Italy): solvent A was H2O containing 0.01% (v/v) acetic
acid, solvent B was 100% acetonitrile. The solvent programwas
a linear gradient (at a flow rate of 0.8 ml/min) starting at 100%
solvent A and increasing to 100% solvent B in 30min. ABAwas
detected with an HP 1040 diode array spectrophotometric
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detector set at 260 nm: ABA was eluted at 17.5 min. Peak areas
of sampleABAwere comparedwith those of a computer-stored
standard, allowing both identification and quantification of the
hormone.
Screening of Inhibitors—The various compounds were dis-
solved in dimethyl sulfoxide and stored at 20 °C as 100 mM
stock solutions. For transport assay, RBC at a 5% hematocrit in
HBSS buffer were preincubated for 30 min at 37 °C with the
compounds at a final concentration of 100 M containing 0.1%
dimethyl sulfoxide, then RBC were centrifuged (15 s at
16,000  g), and pellets were washed once with 1.6 ml of ice-
cold HBSS. Cells were resuspended at a 5% hematocrit and
incubated with 200 nM [3H]ABA for 5 min. After washing, the
intraerythrocytic ABA concentration was estimated by count-
ing the cell radioactivity.
Purification of Bio-ABA-binding Proteins—A volume of 300
l of resealed ghosts (1 mg/ml) was incubated with 100 M
bio-ABA in the presence or absence of excess unlabeled ABA
(10 mM) for 3 h and the membranes were irradiated with UV
light (0.4 Joules) for 5 min. After UV irradiation, the mem-
branes were centrifuged for 10 min at 100,000  g at 4 °C and
the pellets were washed once with ice-cold PBS by centrifuga-
tion and solubilized in lysis buffer (150 mM NaCl, 50 mM Tris-
HCl, pH 7.4, 1% Nonidet P-40) with a protease inhibitor mix-
ture for mammalian cells (Sigma). A volume of 300 l of
magnetic streptavidin-coated beads (10 mg/ml, binding capac-
ity: 600 pmol biotin/mg resin, FLUKA, Italy) was washed 3
times with isotonic buffer (150 mM NaCl, 10 mM Tris-HCl, 1
mM CaCl2, 0.2 mM EDTA) and incubated with the solubilized
samples overnight at 4 °C with mild shaking. Then, the beads
were washed 3 times with isotonic buffer, resuspended in
Laemmli sample buffer, and heated for 5 min at 99 °C. The
supernatant was collected and the bio-ABA-binding proteins
were analyzed by SDS-PAGE and Western blot using an anti-
streptavidin-HRP antibody; gels were stainedwith ProSieve Blu
Protein Staining solution (Lonza, Italy). Blots were also probed
with a primarymAb against Band 3 (Santa Cruz Biotechnology)
and a secondary anti-mouse IgG-HRP antibody.
Reconstitution of Purified Band 3 into Liposomes—Native
Band 3 was purified from white ghosts after stripping of
peripheral proteins, as described above. The stripped ghosts
(1 mg/ml in H2O) were incubated for 10 min at 4 °C with 1%
(w/v) -octyl glucopyranoside (OG) (Sigma). After centrifuga-
tion at 100,000  g for 10 min at 4 °C, the supernatants were
supplemented with 1/10 (v/v) of 400 mM K2HPO4, pH 7.5, and
applied directly to a diethylaminoethyl-cellulose (DE-52 pre-
swollen microgranular, Whatman, Dassel, Germany) anion
exchange column (0.6 ml of resin/mg of solubilized protein)
pre-equilibrated with 40 mM K2HPO4, pH 7.5, containing 0.5%
OG (DE-52 buffer). The column was washed with 3 column
volumes of DE-52 buffer and then with 3 volumes of 0.15 M
NaCl, 0.15 M K2HPO4, pH 7.5, containing 0.5% OG, which
removed the majority of contaminant proteins. Band 3 was
eluted with 1 MNaCl (step 1) and with 1.5 MNaCl (step 2), both
containing 0.15 MK2HPO4, pH 7.5, and 0.5%OG. The fractions
eluted from the column were subjected to protein assay and
SDS-PAGE (10% polyacrylamide gels) was performed after
dialysis in isotonic buffer and concentration of the fractions
with Amicon Ultra. Western blot was performed on 1–2 g of
the fractions with a primary mAb against Band 3 and a second-
ary anti-mouse IgG-HRP antibody.
The liposomes and proteoliposomes were composed of total
lipids extracted from erythrocyte membranes as described in
Ref. 26. Briefly, the dried lipids film (0.8–1mg) was mixed with
2 ml of the proteins eluted from the DE-52 at 1 M NaCl, 0.15 M
K2HPO4, pH 7.5 (protein concentration range, 8 to 10 g/ml,
proteo-1), and at 1.5 M NaCl, 0.15 M K2HPO4, pH 7.5 (protein
concentration range, 0.6 to 1.2 g/ml, proteo-2), both contain-
ing 1% OG (final concentration). The resulting emulsions were
vortexed and sonicated 30 s on ice for 3 times. The sonicated
solutions were extensively dialyzed against 5 liters of isotonic
buffer for 42 h at 4 °C. Control liposomes were prepared with-
out the addition of any protein. After dialysis the liposomes and
proteoliposomes were centrifuged at 100,000 g for 10 min at
4 °C, and the pellets were resuspended in 0.3 ml of isotonic
buffer. The total lipids in the proteoliposome and liposome
were determined on 5–10-l aliquots, as described (26), and
proteins were determined after addition of 1% Triton X-100 in
10–100 l, using the Lowry assay (28).
Transport Assays in Liposomes and in Band 3-reconstituted
Proteoliposomes—To test ABA transport in liposomes and pro-
teoliposomes, proteo-2 and control liposomes were incubated
in isotonic buffer at 22 °C with 100 nM [3H]ABA from 0 to 30
min for the time course experiments, or for 30min, with 500 nM
[3H]ABA, 500 nM [3H]NAD, or 3.5 M [35S]sulfate. To inhibit
Band 3 transport, ghosts were preincubated without (control)
or with 100 M DIDS (Sigma) that was dissolved at 1 mM con-
centration with 0.1 M KHCO3 for 30 min at 37 °C and then
centrifuged once at 100,000 g. Pellets were resuspended at 1
mg/ml in 40 mM K2HPO4, pH 7.5, with 1% OG. Band 3 was
purified and proteoliposomes were obtained as described
above. Transport assays were performed by incubating the pro-
teoliposomeswith 100nM [3H]ABAor 3.5M [35S]sulfate for 30
min. At the various time points, 50-l aliquots (each sample
was assayed in triplicate) were filtered on a glass fiber paper
(GF/CWhatmanTM). Filters were washed with 3 ml of isotonic
buffer on ice, dried, and the radioactivity was determined using
a Packard -counter.
Determination of Intracellular cAMP Levels—RBC were
resuspended inHBSS at a 50% hematocrit and preincubated for
15 min with 250 M cAMP phosphodiesterase inhibitor 3-
isobutyl-1-methylxanthine (Sigma). Then, duplicate 500-l ali-
quots were incubated for 5minwithout (control) or with 10M
ABA, in the absence or presence of 10 M analog #10 (29), or
100 M DIDS (stock solution was dissolved in 0.1 M KHCO3 at
a concentration of 1 mM). The intracellular cAMP concentra-
tion was determined by RIA, as described (12).
Determination of ATP Release from RBC—Washed erythro-
cytes were diluted to a 0.05% hematocrit in HBSS. The extra-
cellular ATP concentration was determined with an ATP
determination kit (Invitrogen), following the manufacturer’s
instruction.
A 250-l sample of erythrocyte suspension at a 0.05% he-
matocrit was incubated without or with 0.1, 1, and 100 M ABA
for 20 min at 22 °C. Cells were then centrifuged for 30 s at
ABA Transporter in Human RBC
13044 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 21•MAY 22, 2015
 at Biblioteche biom
ediche U
niversita' di Torino on M
arch 14, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
16,000 g and 20 l of the supernatants were added to 180 l
of reaction buffer in each well of a 96-well plate.
Luminescence was measured using a FLUOstar OPTIMA
(BMG Labtech, Ortenberg, Germany). ATP concentrations in
the experimental samples were calculated from the ATP stan-
dard curve.
Statistical Analysis—Data were compared by means of the
Student’s unpaired t test, or one-way analysis of variance. Sta-
tistical significance was set at p  0.05. Statistical analysis was
performed using the GraphPad Prism Software (GraphPad
Software Inc.).
Results
ABA Binding and Influx into Erythrocytes—Previous experi-
ments of [3H]ABA binding to intact human granulocytes (12)
had revealed two processes characterized by different affinity
constants: (i) a high affinity binding (Kd  11 nM), which was
interpreted as ABA binding to receptor and (ii) a low affinity
binding (Kd 500M), whichwas interpreted as ABA interact-
ing with intracellular proteins, after influx into the cells.
First we examined some general properties of ABAuptake by
intact RBC. ABA influx occurred over a pH range from 6.7 to
8.0, with a 50% decrease at pH 8.0 compared with pH 6.7.
Transport was reduced by 90% in RBC pre-treated with 1%
glutaraldehyde and was completely abrogated at 0 °C. No
appreciable variation of ABA influx was observed over a tem-
perature range between 20 and 37 °C. Therefore, ABA trans-
port was analyzed at 22 °C and at pH 7.4. The time course of
ABA influx in RBC is shown in Fig. 1A. When RBC were
exposed to 200 nM [3H]ABA, a rapid uptake occurredwithin the
first 15min and intraerythrocytic concentrations remained sta-
ble thereafter for up to 60 min.
Next, RBC were incubated in HBSS with increasing concen-
trations of extracellular [3H]ABA, and the initial rate of ABA
uptake was measured. As shown in Fig. 1B, at low [3H]ABA
concentrations (3.5 to 56 nM), a saturable binding was observed
and the Scatchard plot analysis indicated the presence of high
affinity binding sites (Kd  52 nM). These results could be
attributed to the interaction between ABA and its receptor
LANCL2, which is expressed in erythrocytes, as demonstrated
below. Conversely, at higher [3H]ABA concentrations (100 to
300 nM), an apparently non-saturable process was observed
(Fig. 1B). RBCwere thus incubated with unlabeled ABA at con-
centrations up to 25 mM and the intracellular ABA was deter-
mined byHPLC analysis (Fig. 1C). Saturation of the transporter
was still not observed up to the highest ABA concentration
tested (25mM). Increasing the extracellular ABA concentration
above this value was not possible due to its insolubility in neu-
tral aqueous solutions (the maximal concentration attainable
being 	50 mM). Thus saturation of the transporter requires
ABA concentrations higher than 25 mM.
LANCL2 Localization in Ghosts—AsABA binding and trans-
port co-exist in RBC, we addressed the question whether
FIGURE 1.ABA influx into human RBC. A, RBC were incubated at a 5% hematocrit with 200 nM [3H]ABA for 0.5, 3, 5, 15, 30, and 60min at 22 °C (circles) or 0 °C
(triangles). At various time points, incubation aliquots were centrifuged, cells werewashed at 0 °C, and the intracellular radioactivity was counted as described
under ”Experimental Procedures.“ ***, p 0.001 for all points of the curve. B, RBCwere incubated in HBSS at a 5%hematocrit for 30 s at 22 °Cwith 3.5, 7, 14, 28,
56, 114, 200, and 300 nM [3H]ABA. Intracellular ABAwas estimated after washing RBC pellets and counting the radioactivity. The inset shows the Scatchard plot
of [3H]ABA from 3.5 to 56 nM. C, RBC were incubated at a 50% hematocrit with 0.025, 0.25, 2.5, 10, and 25mM unlabeled ABA. Intracellular ABA concentrations
were determined on deproteinized cell extracts by HPLC analysis, as described under ”Experimental Procedures.“
ABA Transporter in Human RBC
MAY 22, 2015•VOLUME 290•NUMBER 21 JOURNAL OF BIOLOGICAL CHEMISTRY 13045
 at Biblioteche biom
ediche U
niversita' di Torino on M
arch 14, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
LANCL2 could function as an ABA transporter, in addition to
its established role as ABA receptor (18, 20). Previous experi-
ments of immunofluorescence labeling of LANCL2, fused with
the C-terminal V5 peptide, with an anti-V5 antibody (18), dem-
onstrated that in transfected CD38/LANCL2 HeLa cells
LANCL2 localizes at the plasmamembrane, although it was not
clear whether as an intrinsic or peripheral protein. To identify
LANCL2 localization, we subjected erythrocyte ghosts to high
ionic strength and alkaline pH in the absence of detergents to
remove the peripheral proteins. After treatment, the ghost pel-
lets, containing transmembrane proteins, and the supernatant,
containing the concentrated peripheral proteins, were analyzed
by SDS-PAGE. Fig. 2 shows a representative Western blot,
probed with a monoclonal anti-LANCL2 antibody (mAb
LANCL2). LANCL2wasmainly present in the supernatant and
only traces of the protein were visible in the membrane pellets
after chemical treatment. The fact that LANCL2 can be
removed from the ghosts by simply increasing ionic strength
and pH demonstrates that LANCL2 is not an integral protein.
This result indicates that LANCL2 cannot be involved in the
direct passage of ABA across the plasma membrane.
Properties of ABA Transport in RBC—To investigate other
properties of ABA transport, RBC were loaded with 200 nM
[3H]ABA and then submitted to 4 sequential washings at 0 or
37 °Cwith 1.5ml ofHBSS. Because theABA content in the RBC
washed at 37 °C was significantly lower compared with that in
RBC washed at 0 °C (Fig. 3A), we conclude that ABA transport
in RBC is equilibrative, allowing movement of ABA across the
plasma membrane down a concentration gradient.
Next, we addressed whether the extracellular ABA uptake
was affected by specific inhibitors of selected transport systems
known to be present in RBC (Fig. 3B). Each of these inhibitors
was used at a final concentration of 100 M. Concerning the
ATP-dependent transport systems, ABA influx was unaffected
either by ouabain, an inhibitor of the Na/K-ATPase, or by
verapamil, indomethacin, or glibenclamide, all inhibitors of the
ATPbinding cassette transportersmultidrug resistance protein
1 (MDRP1), and cystic fibrosis transmembrane conductance
regulator. As far as themechanisms of facilitated diffusion pres-
ent in the erythrocytes are concerned, the inhibitors of the
nucleoside transporter and the glucose transporter were inef-
fective. Instead,DIDS, an inhibitor of the anion exchanger Band
3, and also of othermembrane transporters expressed in nucle-
ated cells, including Na,K-ATPase (30, 31), Ca2-ATPase (32),
and canalicular bile salt transport system (33), reduced ABA
uptake by 70%. We also tested DIDS at a final concentration of
500 M, in the absence or presence of 2.5 mM ABA for 5 min.
ABA influx intoRBC, asmeasured byHPLCanalysis, was inhib-
ited by	90%.
DIDS is also an irreversible inhibitor of the monocarboxylic
acids transporter (MCT-1) (34). Because the MCT-1-specific
inhibitor AR-C155858 at 100 M had only a limited inhibitory
effect on ABA influx (10%), a major role of MCT-1 in ABA
transport in RBC is unlikely (Fig. 3B). These results suggest that
Band 3 is the major contributor to ABA transport in RBC. ABA
is a weak organic acid (pK  4.8); protonated ABA (ABA-
COOH) is the main form at low pH, whereas de-protonated
ABA (ABA-COO) prevails at pH
 4.8. Thus, at physiological
pH (around 7.4), de-protonated ABA is the predominant form
of the hormone transported by Band 3.
FIGURE 2. LANCL2 is a peripheral protein in ghosts. Twenty g of white
ghosts were washed to remove extrinsic proteins as described under ”Exper-
imental Procedures.“ White ghosts before treatment (lane 1), the concen-
trated supernatants from the washings, containing the extrinsic proteins
(lane 2), and the washed pellets, containing integral proteins only (lane 3)
were analyzed by Western blotting using an anti-LANCL2 monoclonal
antibody.
FIGURE 3. ABA efflux from RBC and screening of ABA influx inhibitors. A, RBC were incubated at a 5% hematocrit with 200 nM [3H]ABA for 30 min at 22 °C
and washed once at 0 °C. An aliquot of RBC suspension was counted to estimate the total intracellular ABA ([ABA]i, lane 1). The rest of the suspension was
divided into 2 aliquots and eachwas further washed 4 times at 0 °C (lane 2) or 37 °C (lane 3) with HBSS. The intraerythrocytic ABA concentration is expressed as
percentage of the total intracellular [ABA]i (lane 1). **, 0.001 p 0.01 comparedwithwhite bar, by t test. B, RBCwere preincubated at a 5% hematocrit for 30
min at 37 °C without (Ctrl) or with each one of the compounds shown in the abscissa, at a 100 M final concentration. After centrifugation and washing the
pellets, cells were incubated at 22 °C with 200 nM [3H]ABA for 5 min and the intracellular radioactivity was measured using a -counter. *, p 0.05 compared
with control (Ctrl); **, p 0.001 compared with Ctrl, by t test. Results shown are the mean S.D. of 3 experiments.
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Chloride Ions Compete withABA for Influx in RBC—Band 3 is
a monovalent anion channel, which mediates the bidirectional
and electroneutral exchange of an anion with another through
the plasma membrane of erythrocytes. The preferentially ex-
changed anions are Cl/HCO3, but Band 3 may also exchange
SO42/H with Cl (35). Thus, we used [35S]sulfate to study
Band 3 functionality in erythrocytes. We performed experi-
ments of [35S]sulfate influx in a chloride-containing buffer
(HBSS) or in a chloride-free buffer (citrate). In RBCwashed and
incubated with chloride-free buffer, the intracellular Cl con-
tent is reduced due to a net loss of Cl driven by the outward
Cl gradient (36). In these conditions, the transport of [35S]sul-
fate increased considerably, compared with its influx in RBC
incubated in the same buffer supplemented with chloride or in
HBSS (Fig. 4A). Thus, absence of competing extracellular Cl
facilitates influx of sulfate. To verify if extracellularClwas able
to compete with the influx of ABA-[COO], influx experi-
ments were carried out in a chloride-free buffer, supplemented
or not with Cl. RBCwere subjected to repeatedwashings in 80
mMNa-citrate buffer at pH 7.4, and incubated at 5% hematocrit
in the presence of 100 nM [3H]ABA, with or without added Cl.
Control cells were incubated in HBSS (chloride buffer). As
shown in Fig. 4B, influx of [3H]ABA was increased in RBC
resuspended in citrate buffer, and when 100 mM NaCl was
added there was a significant decrease of [3H]ABA influx rela-
tive to control.
Binding of Bio-ABA to Band 3—Next, we investigated
whether ABA could bind to Band 3. Photochemical cross-link-
ing of a ligand to its specific protein transporter or exchanger is
frequently used to stabilize the complex and provide informa-
tion difficult to obtain in a dynamic situation (37, 38). We used
a biotinylated analog of ABA for binding experiments (39). In
the bio-ABA molecule, the ABA moiety can be photoactivated
at 254 nm (40) and can bind covalently to ABA-binding pro-
teins, whereas the biotin moiety is detectable with the HRP-
streptavidin system. The experiments were carried out on
resealed ghosts that expose the extracellular side of RBCmem-
branes (right side-out ghosts). Resealed ghosts were incubated
with 100 M bio-ABA under UV light for 5 min on ice, excess
bio-ABA was removed by washing and biotinylated proteins
were purified on magnetic streptavidin-coated beads, after sol-
ubilization. The samples were subjected to SDS-PAGE and
Western blot, and streptavidin conjugated to horseradish per-
oxidase (HRP) was used for protein band detection. Bio-ABA
predominantly labeled a 100-kDa band, with a shape and
molecular size similar to Band 3 (Fig. 5A, lane 1). To confirm
that the 100-kDa band was indeed Band 3, the samemembrane
was also stained with streptavidin-HRP or with a mAb against
Band 3 (Fig. 5A, lane 2). The specificity of the binding between
FIGURE 4. Chloride ions competewith ABA for influx into RBC. RBCwere washed at a 5% hematocrit with HBSS (Ctrl) or with sodium citrate buffer. Washed
cells were then resuspended in the same buffer used for washing and incubated with A, 3.5 M [35S]sulfate or B, 200 nM [3H]ABA for 5 min in the presence or
absence of 100 mM NaCl. After centrifugation, cells were washed in the appropriate buffer and the intracellular radioactivity was measured. **, p  0.05,
compared with control (Ctrl), by t test. ***, p 0.0001 compared with citrate buffer. Results are the mean S.D. of 3 experiments.
FIGURE 5. Band 3 from RBC ghosts binds bio-ABA. Resealed ghosts were
incubatedwith 100Mbio-ABA for 3h at 22 °C. AfterUV irradiation (0.4 Joules
for 5 min), ghosts were washed and solubilized, and bio-ABA-binding pro-
teins were purified using streptavidin-coated beads and subjected to SDS-
PAGE andWestern blot. A, a representative nitrocellulosemembrane stained
with streptavidin-HRP (lane 1), or with a monoclonal anti-Band 3 antibody
(lane 2). B, a representative nitrocellulose membrane from an incubation of
resealed ghosts with bio-ABA, without (lane 1), or with excess unlabeled ABA
(lane 2), stained with an anti-Band 3 monoclonal antibody.
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Band 3 and ABA was demonstrated by displacement of bio-
ABA by excess non-biotinylated ABA (Fig. 5B, lane 2).
ABA Transport Occurs Across Band 3-reconstituted Proteo-
liposomes—Under physiological conditions, Band 3 is present
in dimeric and tetrameric forms in erythrocyte membranes
(41). Moreover, it has been previously demonstrated that treat-
ment with OG induces Band 3 aggregation into high molecular
weight oligomers, without significant modification of the pro-
tein secondary structure (42). Indeed, SDS-PAGE of OG-solu-
bilized, purified Band 3, shows a predominant band at 100 kDa
(corresponding to the monomer) and another at 250 kDa, cor-
responding to dimers (Fig. 6A). After removal of the peripheral
proteins, Band 3 was purified from human erythrocyte ghosts
solubilized in 1% OG by anion exchange chromatography. Fig.
6A shows the SDS-PAGE and Western blot of the final purifi-
cation steps: the 1 M NaCl eluate, containing Band 3 along with
several contaminating proteins, and the 1.5 MNaCl eluate, con-
taining highly purified Band 3, both in monomeric and dimeric
forms. Reconstitution of proteoliposomes with total erythro-
cyte ghost proteins, or with the 1 and 1.5 M NaCl eluates from
the DE-52 column, showed a progressive increase of [3H]ABA
influx along with the enrichment of Band 3 (Fig. 6A). To verify
the functional activity of reconstituted Band 3, we compared
the influx of ABA into proteoliposomes reconstituted with
FIGURE 6. Purification, reconstitution of Band 3, and ABA transport in liposomes and proteoliposomes. A, [3H]ABA uptake by proteoliposomes recon-
stituted with total ghost proteins, or with proteins eluted from a DE-52 column with 1 M NaCl (Proteo-1) or 1.5 M NaCl (Proteo-2). The proteoliposomes were
incubated with 100 nM [3H]ABA for 30 min at 22 °C; samples were then filtered on glass fiber paper as described under ”Experimental Procedures“ and the
radioactivity of the filter was measured in a -counter. Results are the mean S.D. of 4 experiments. The inset shows an SDS-PAGE separation stained with
ProSieve Blu Protein Staining of 10g of solubilized ghost proteins eluted from a DE-52 columnwith 1 M NaCl (lane 1) or 1.5 M NaCl (lane 2). Western blot of 1
gof the samesample loaded in lane2, probedwithananti-Band3monoclonal antibody (lane3).B,Proteo-2 liposomeswere incubated for 30minat 22 °Cwith
500 nM [3H]ABA, 500 nM [3H]NAD, or 3.5M [35S]sulfate. ***, p 0.001; *, 0.001 p 0.01 comparedwithwhite bar, by t test. C, proteoliposomes reconstituted
with Band3purified fromghosts pretreated, or not (Ctrl), with 100MDIDSwere incubated for 30minwith 100nM [3H]ABAor 3.5M [35S]sulfate. ***,p0.001;
**,p0.05 comparedwith the respective control (Ctrl) by t test.D, time courseofABA influx inproteo-2 (black squares) and in liposomes (open circles) thatwere
incubatedwith 100 nM [3H]ABA for 0, 5, 15, and 30min at 22 °C. At the times indicated, incubation sampleswere filtered onglass fiber filters, washed in isotonic
buffer, and the incorporated radioactivity was measured with a -counter. ***, p  0.001 compared with proteo-2, by t test (mean  S.D. from n  3
experiments).
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purified Band 3 with the influx of [3H]NAD and [35S]sulfate,
taken as negative and positive controls, respectively (Fig. 6B).
No transportwhatsoever of [3H]NAD (nor of [14C]glucose, data
not shown) was detectable with the same Band 3-reconstituted
proteoliposomes, which conversely did transport labeled sul-
fate, as well as ABA. To inhibit Band 3 transport, white ghosts
were treated with 100 M DIDS for 30 min, allowing the irre-
versible binding of DIDS to Band 3. Band 3 was then purified
and reconstituted into proteoliposomes, as described under
“Experimental Procedures.” Fig. 6C shows that the transport of
labeled sulfate and ABA in proteoliposomes reconstituted with
purified Band 3 pre-treatedwithDIDS is strongly reduced com-
pared with the control. These results indicate that reconstitu-
tion of Band 3 into proteoliposomes restores a functional Band
3, capable of transporting sulfate and ABA, and that DIDS
inhibits both the transport of sulfate and that of ABA.
To evaluate the extent of a nonspecific adsorption of ABA to
the lipid bilayer, liposomes prepared with or without purified
Band 3 were incubated with 100 nM [3H]ABA. As shown in Fig.
6D, the concentration of intravesicular ABA in the proteolipo-
somes reached 0.2 pmol/mg of lipid in 30 min. Conversely, the
amount of ABA associated with liposomes was considerably
lower (about 0.02 pmol/mg lipid) and did not increase with
incubation time. The	0.1% fraction of total ABApresent at pH
7.4 in the protonated form (ABA-COOH), which can diffuse
through the lipid bilayer, as already demonstrated in higher
plants (43), could account for this low amount of lipid-associ-
ated ABA.
ABA Stimulates ATP Release from RBC via Activation of
Adenylate Cyclase—Erythrocyte stress is known to modulate
vascular tone by inducing the release of ATP from intact RBC
via the activation of adenylate cyclase (AC) and the consequent
increase of the intraerythrocytic cAMP concentration [cAMP]i
(44, 45). ABA is known to activate AC and induce an increase
of [cAMP]i in several nucleated cell types, including human
granulocytes (12), the rat insulinoma cells RIN-m and INS-1
(17, 18), and aortic endothelial cells (46). Thus, we first investi-
gated whether ABA influx into RBC induced an increase of the
[cAMP]i.
The [cAMP]i increased by 100 10% in RBC incubated for 5
min with 0.1 M ABA, as compared with untreated cells (Fig.
7A). It was previously demonstrated that a synthetic ABA ana-
log, compound #10, which inhibits the ABA-triggered increase
of [cAMP]i in human granulocytes, competes with ABA for
binding to LANCL2 and inhibits the functional activation of
granulocytes induced by exogenous ABA (29). We observed
that analog #10 was indeed able to inhibit the [cAMP]i increase
induced by ABA in erythrocytes, indicating that LANCL2 is
involved in the intraerythrocytic activation of AC by extracel-
lular ABA (Fig. 7A). Preincubation of RBC with DIDS pre-
vented the increase of the [cAMP]i in the presence of ABA (Fig.
7A), confirming that a functional Band 3 is required for ABA
influx and AC activation. No effect of DIDS or of compound
#10 on cAMP levels was observed in RBC incubated without
ABA (data not shown).
We then addressed the question of whether ABA could
induce ATP release from intact erythrocytes. To this purpose,
we preliminarily tested whether ABA could cause hemolysis.
Erythrocyte suspensions (250 l), without (control) or with
increasing ABA concentrations (from 0.1 M to 1 mM), were
incubated for 20min at 22 °C, centrifuged for 30 s at 16,000 g,
and the absorbance of the supernatants was measured at 405
nm. No difference was observed between control and ABA-
containing incubations, allowing the conclusion that ABA does
not induce RBC lysis over the concentration range tested. Thus,
RBCwere incubated at a hematocrit of 0.05% without (control)
or with increasing ABA concentrations and ATP release was
measured after 0 and 20 min. Fig. 7B shows that 0.1 M ABA
was sufficient to induce ATP release from erythrocytes.
Finally, we investigated the possible causal role of AC activa-
tion in the ABA-induced ATP release by inhibiting the genera-
tion of cyclic AMP with the adenylate cyclase inhibitor dide-
oxyadenosine, or with the PKA-specific myristoylated peptide
inhibitor (I-PKA). As shown in Fig. 7C, both dideoxyadenosine
and I-PKA inhibited the ABA-triggered ATP release from
intact RBC, indicating a causal role of the [cAMP]i increase in
the ABA-induced ATP efflux.
Discussion
In the present study, we show for the first time that an ABA
transport is present in human erythrocytes. RBC represent a
convenient model system for the study of ABA transport in
mammalian cells, for two reasons: (i) RBC plasma membranes
(ghosts) can be easily isolated and resealed, yielding transport-
competent vesicles (47), and (ii) RBC express the ABA receptor
LANCL2, which upon ABA binding stimulates AC in several
animal cell types (12–18, 48), thus triggering the first step of the
intracellular ABA signaling pathway after ABA influx. The first
member of the LANCL family, LANCL1, was indeed isolated
from human erythrocyte membranes, where it is present as a
peripheral membrane protein (49). Our results demonstrate
that LANCL2 is present in RBC ghosts, as detected byWestern
blot with a LANCL2-specific monoclonal antibody, and is a
peripheral membrane protein. Because LANCL2 is located on
the intracellular side of the plasmamembrane, an ABA trans-
port system is required to allow the extracellular hormone to
cross the plasma membrane and bind to its receptor.
The results obtained in this study demonstrate that transport
of ABA indeed occurs across both RBC membranes and
resealed ghosts and that removal of LANCL2, by means of
chemical treatments in the absence of detergents, does not
affect ABA transport, indicating that LANCL2 is neither nec-
essary nor adjuvant for ABA influx into RBC.
The ABA transporter in RBC is identified as the anion trans-
porter Band 3 on the basis of the following results: (i) proteoli-
posomes reconstituted with purified Band 3 are able to trans-
port ABA and sulfate, and (ii) the specific Band 3 inhibitor
DIDS inhibits influx of ABA. The fact that Band 3 binds bio-
ABA and bio-ABA can be displaced by excess ABA confirms
that a specific interaction occurs between ABA and the
transporter.
Band 3 exhibits half-saturation at chloride concentrations of
	45 mM, both in intact RBC and in RBC ghosts (50, 51). Thus,
it may not be surprising that saturation of ABA transport was
not observed up to ABA concentrations of 25 mM.
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FIGURE 7. The ABA antagonist #10 and Band 3 inhibitor DIDS inhibit the ABA-induced [cAMP]i rise andATP release. A, RBCwere preincubated at a 50%
hematocrit with 250Mof the cAMPphosphodiesterase inhibitor 3-isobutyl-1-methylxanthine for 15min; cells were then incubated at 22 °C for 5minwithout
(Ctrl) or with 0.1 M ABA, without or with 10 M #10 or 100 M DIDS. The intraerythrocytic cAMP concentrations were measured as described under ”Experi-
mental Procedures.“ ***, p 0.03 compared with control (Ctrl). B, erythrocytes were incubated at a 0.05% hematocrit without or with 0.1, 1.0, or 100 M ABA
for 20min andATP released from the intact RBCwas thendetermined as described under ”Experimental Procedures.“ **, p 0.01 comparedwith control (Ctrl).
C,RBCwerepreincubated for 15min at 37 °C at a 0.05%hematocritwithout orwith 100M2,3-dideoxyadenosine (ddA), a specific adenylate cyclase inhibitor,
or with 10M of a specific myristoylated peptide inhibitor of PKA (I-PKA). RBC were then incubated without or with 100M ABA for 20min at 22 °C. Cells were
centrifugedandATPcontent in the supernatantwasmeasuredasdescribedunder ”Experimental Procedures.“ Results are expressedas thedifferencebetween
theATP concentrationmeasured after 20min incubation and theATP concentration at time0. ***,p0.001 comparedwith control (Ctrl); *,p0.05 compared
with 100 M ABA, by t test (mean S.D., n 3 experiments).
FIGURE 8. Schematic representation of the ABA-induced [cAMP]i increase and ATP release. In themicrocirculation, paracrine ABA produced by inflammatory
cells enters into RBC across Band 3. Intracellular ABA binds and activates the LANCL2 receptor with consequent activation of AC and overproduction of cAMP.
Downstreamof the cAMP increase, ATP is released fromerythrocytes. Specific inhibitors of theABA signalingpathway are indicatedbydashedarrows.DIDS, a Band3
inhibitor; #10, a synthetic ABA antagonist of the LANCL2 receptor; ddA, a adenylate cyclase inhibitor; I-PKA, a PKA-specificmyristoylated peptide inhibitor.
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Protonated ABA can diffuse through the lipid bilayer (43);
however, a very low percentage of ABA is protonated at the
near-neutral pH present in animal fluids and tissues, making
the presence of a transport system essential for ABA trafficking
between intra and extracellular fluids.
Once internalized in RBC, ABA induces intracellular cAMP
formation, leading to a regulated release of ATP (Fig. 8). The
following events are required for intraerythrocytic activation of
AC to occur, with consequent [cAMP]i increase: (i) ABA trans-
port through Band 3, as demonstrated by inhibition of the
[cAMP]i increase by DIDS, and (ii) ABA binding to and activa-
tion of LANCL2, as demonstrated by inhibition of the [cAMP]i
increase by the ABA antagonist analog #10. It has been previ-
ously reported that in erythrocytes a [cAMP]i increase induces
ATP release through two different mechanisms: (i) via pan-
nexin 1, in response to RBCexposure to lowO2 or (ii) viaVDAC
channels, in response to -adrenergic receptor activation (45).
It can be hypothesized that ABA released from activated
inflammatory cells (granulocytes, monocytes, microglia) and/
or from vascular smooth muscle cells could locally reach con-
centrations in the 100 nM range (up from 1 to 10 nM basal
plasma values) (52) in the microcirculation.
ABA concentrations in the 10–100 nM range were indeed
measured in human atherosclerotic plaques (13). Moreover,
based on the amount of ABA that can be released by activated
humanmonocytes (13), an ABA concentration of 100 nM could
be attained locally by	8 106 cells, extravasated in a volume
of 400 l. This monocyte density can be easily reached under
inflammatory tissue conditions (53, 54). As summarized in Fig.
8, extracellular ABA could then trigger a cAMP-dependent
ATP release from erythrocytes, thus contributing to the vaso-
dilator response to local inflammation.
In nucleated cells, Band 3 (SLC4A1/AE1) is present along
with two other anion transporters, SLC4A2/AE2 and SLC4A3/
AE3 (55). Whether in these cells AE1 alone, or all three trans-
porters are capable of ABA transport remains to be established.
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